about
Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease PathogenesisLack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 geneDetection of Mycoplasma pneumoniae in simulated and true clinical throat swab specimens by nanorod array-surface-enhanced Raman spectroscopyMicroRNA regulation of human protease genes essential for influenza virus replicationComparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1).Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice.Role of cytokines in the development and maintenance of memory T cells during respiratory viral infection.Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.Rapid and sensitive detection of rotavirus molecular signatures using surface enhanced Raman spectroscopy.The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c miceReal-time detection of virus particles and viral protein expression with two-color nanoparticle probes.Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.Detection and differentiation of avian mycoplasmas by surface-enhanced Raman spectroscopy based on a silver nanorod array.Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice.Therapeutic targeting of respiratory syncytial virus G-protein.Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionIdentification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice.Antiviral responses by Swine primary bronchoepithelial cells are limited compared to human bronchoepithelial cells following influenza virus infection.Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P.Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challengeBat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment.Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections?Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance PRNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionHuman metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment.Molecular and cellular mechanisms in the viral exacerbation of asthma.Pause on avian flu transmission research.siRNA Genome Screening Approaches to Therapeutic Drug Repositioning.RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.Transmission studies resume for avian flu.Animal models for evaluation of influenza vaccines.Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsUnderstanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.Respiratory syncytial virus: prospects for new and emerging therapeutics.Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication.
P50
Q26823449-79126B11-276D-4205-9CAE-2420575AEB67Q28276209-0EE0185B-76E8-4A6D-B03F-508A8990C26FQ28475926-49DC0BE5-7648-43DE-B83D-446FBE498E56Q28483683-486D0B41-8887-4BAC-A5BD-F56E3715A616Q30400180-809C6AAC-AF19-494B-B35F-8717D5C6BA91Q30429302-D77F9070-1CAD-4411-B74E-6FF696EB595BQ33338037-B771742D-B2DA-4815-8F18-B581E3A54948Q33558356-2ED3A061-23E4-4BC4-9CB6-EDD748F44356Q33564226-B998BCD4-01F6-4AC9-8EAE-799BF120E738Q33780466-53D07733-03C5-4B36-9461-9076E6CE7FD9Q33843360-EED8AB2F-4066-4FB4-8B0A-D5D4EC6F9E1FQ34120278-90B9C92D-9E1F-4612-9091-BF934F9A4144Q34243825-A31BEA13-E662-4A0E-B58F-26504C9FB9BEQ34540179-FB63821A-4C46-4E59-9AC6-4E9A75B176D6Q34603346-15B41F0B-84F0-4AFC-BC5D-7C51A1DD2987Q34735848-4D695D79-770F-400C-90EA-CF57E1F88D94Q34778943-9D4F47F7-060B-48A3-A08B-3675FB8E27D4Q34785589-F6058DCF-CC20-4604-822A-E173354B29F1Q34789319-2568FEAC-0F38-4D6D-B760-1C2336476227Q34854966-E9C7C240-6771-4909-9B60-2A4F88D10C46Q34990420-24D042CD-2368-437F-811C-897D14A0A84AQ34996665-044B45E8-545C-4937-81CA-F2E24A37AFC5Q35077892-877EFBDA-E7F7-4BCD-B685-A1E2A143C789Q36016500-82A90345-5061-47EE-B703-00555F807465Q36251680-8D0E4B1C-8B31-4016-B3F6-FB4ED995FF9BQ36267147-24F43B7E-8E82-4667-BDAE-ACB0FF2366CEQ36464353-73624C78-9FCE-4C21-8A7E-2DD9EF392B69Q36994716-47AB5666-500E-4E69-BCDB-578B1C09FF6EQ37006795-5424A4E8-D0E4-44B7-BA80-9315C8E99125Q37232888-A6CF4C23-C922-4F8D-B3BD-C2927CD3BDB3Q37257954-5D9D0859-026E-468C-9502-09206F8BBDE0Q37265666-F183855B-DFB1-4470-B46C-168FD2A36C6FQ37277365-E0CBD645-D0AE-4689-BC9F-92939DFF76A2Q37333053-DD2BC1CC-B7FF-4C06-BE7C-FC90394CFA99Q37338331-637C0C6A-D143-4787-A1D9-09B25332383DQ37600679-0523E8AA-CCF6-426F-B139-2ECD3E019721Q37698939-D089C5F9-BAE9-489F-AE4C-2931C5CE4AE9Q38660842-DC06DED6-558F-4DC9-AA0A-21802B4F8D1BQ38675686-06381F93-A84D-436E-9C02-BAE3A391D7FAQ39297218-97201871-E8A0-4E20-A138-FD3A8795EE9C
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ralph A. Tripp
@ast
Ralph A. Tripp
@en
Ralph A. Tripp
@es
Ralph A. Tripp
@nl
Ralph A. Tripp
@sl
type
label
Ralph A. Tripp
@ast
Ralph A. Tripp
@en
Ralph A. Tripp
@es
Ralph A. Tripp
@nl
Ralph A. Tripp
@sl
altLabel
Ralph Tripp
@en
prefLabel
Ralph A. Tripp
@ast
Ralph A. Tripp
@en
Ralph A. Tripp
@es
Ralph A. Tripp
@nl
Ralph A. Tripp
@sl
P214
P244
P106
P1153
7006014151
P21
P213
0000 0000 5405 4216
P214
P244
no2008139047
P31
P496
0000-0002-2924-9956
P735
P7859
lccn-no2008139047